BIOGEN INC. Additional Paid-in Capital 2008-2026 | BIIB
Beta
What is BIOGEN INC.'s current additional paid-in capital?
BIOGEN INC. (BIIB) annual additional paid-in capital for 2025 was $863.1M, a 51.58% increase from 2024. BIOGEN INC. additional paid-in capital for the quarter ending March 31, 2026 was $896.7M.
What was BIOGEN INC.'s additional paid-in capital in 2024?
BIOGEN INC. annual additional paid-in capital for 2024 was $569.4M, a 88.23% increase from 2023.
What was BIOGEN INC.'s additional paid-in capital in 2023?
BIOGEN INC. annual additional paid-in capital for 2023 was $302.5M, a 312.69% increase from 2022.
Additional Paid-in Capital History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$0
→
FY2025
$863.1M
080910111213141516171819202122232425
5 years selected
Additional Paid-in Capital History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $863.1M | +51.6% | 10-K |
| FY2024 | $569.4M | +88.2% | 10-K |
| FY2023 | $302.5M | +312.7% | 10-K |
| FY2022 | $73.3M | +7.5% | 10-K |
| FY2021 | $68.2M | - | 10-K |
| FY2020 | $0 | - | 10-K |
| FY2019 | $0 | - | 10-K |
| FY2018 | $0 | -100.0% | 10-K |
| FY2017 | $97.8M | - | 10-K |
| FY2016 | $0 | - | 10-K |
| FY2015 | $0 | -100.0% | 10-K |
| FY2014 | $4.20B | +4.3% | 10-K |
| FY2013 | $4.02B | +4.4% | 10-K |
| FY2012 | $3.85B | -7.9% | 10-K |
| FY2011 | $4.19B | +7.4% | 10-K |
| FY2010 | $3.90B | -32.6% | 10-K |
| FY2009 | $5.78B | -4.8% | 10-K |
| FY2008 | $6.07B | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →